Skip to main content
logo
Medtronic plc (MDT)
NYSE: MDT · Real-Time Price · USD
91.27
+0.69 (0.76%)
At close: Aug 14, 2026, 4:00 PM EDT
91.01
-0.26 (-0.28%)
Pre-market: Aug 17, 2026, 5:40 AM EDT

Revenue

Millions USD. Fiscal year is May - Apr.
Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013
Period Ending
Apr '26 Apr '25 Apr '24 Apr '23 Apr '22 Apr '21 Apr '20 Apr '19 Apr '18 Apr '17 Apr '16 Apr '15 Apr '14 Apr '13
Cardiac Rhythm & Heart Failure Revenue
7.50B6.39B
Structural Heart & Aortic Revenue
3.82B3.55B
Coronary & Peripheral Vascular Revenue
2.66B2.54B
Cardiovascular Revenue
13.98B12.48B
Cranial & Spinal Technologies Revenue
5.22B4.97B
Specialty Therapies Revenue
3.00B2.94B
Neuromodulation Revenue
2.07B1.93B
Neuroscience Revenue
10.29B9.85B
Surgical & Endoscopy Revenue
6.76B6.50B
Acute Care & Monitoring Revenue
2.05B1.91B
Medical Surgical Revenue
8.82B8.41B
Diabetes Revenue
3.11B2.76B
Other Segment Revenue
174.00M48.00M
Revenue (Other)
--
Revenue (Total)
36.36B33.54B

Revenue by Geography

Millions USD. Fiscal year is May - Apr.
Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013
Period Ending
Apr '26 Apr '25 Apr '24 Apr '23 Apr '22 Apr '21 Apr '20 Apr '19 Apr '18 Apr '17 Apr '16 Apr '15 Apr '14 Apr '13
U.S. Revenue
18.10B17.17B
Non-U.S. Developed Markets Revenue
-10.20B
Emerging Markets Revenue
-6.20B
Total International Revenue
18.26B16.37B
Revenue (Other)
-1.00M
Revenue (Total)
36.36B33.54B

EBIT

Millions USD. Fiscal year is May - Apr.
Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013
Period Ending
Apr '26 Apr '25 Apr '24 Apr '23 Apr '22 Apr '21 Apr '20 Apr '19 Apr '18 Apr '17 Apr '16 Apr '15 Apr '14 Apr '13
Cardiovascular Operating Profit
3.67B3.34B
Neuroscience Operating Profit
3.06B3.03B
Medical Surgical Operating Profit
2.13B2.07B
Other Segment Operating Profit
106.00M214.00M
Operating Income (Other)
-2.50B-2.71B
Operating Income (Total)
6.47B5.96B

Key Performance Indicators

Millions USD. Fiscal year is May - Apr.
Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013
Period Ending
Apr '26 Apr '25 Apr '24 Apr '23 Apr '22 Apr '21 Apr '20 Apr '19 Apr '18 Apr '17 Apr '16 Apr '15 Apr '14 Apr '13
Cardiovascular Organic Revenue Growth
9.30%6.30%
Neuroscience Organic Revenue Growth
3.10%5.20%
Medical Surgical Organic Revenue Growth
2.90%0.80%
Diabetes Organic Revenue Growth
7.90%11.50%
Total Organic Revenue Growth
5.80%4.90%